Data as of Dec 17
| +0.45 / +1.47%|
The 19 analysts offering 12-month price forecasts for Pfizer have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 29.00. The median estimate represents a +9.25% increase from the last price of 31.12.
The current consensus among 21 polled investment analysts is to Buy stock in Pfizer. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.